Physician profile
Roberto Ruiz
NPI 1902149727
$1,621.38
in general payments reported to CMS, 2019-2025
9 companies · $355 in 2025
The $355 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2021: $145 · 2022: $80.29 · 2023: $391 · 2024: $530 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,276.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $581.78 | 2023-2024 | Advantagerib, Sternalock Blu System |
| Abbott Laboratories | $428.60 | 2021-2025 | Ensite Precision, Freestyle Libre 3 |
| Atricure, INC. | $125.07 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Amarin Pharma, INC. | $120.32 | 2019 | |
| Medtronic, INC. | $105.09 | 2023 | Mycarelink |
| Teva Pharmaceuticals USA, INC. | $85.73 | 2024 | Austedo Xr |
| Intuitive Surgical, INC. | $80.29 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.95 | 2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $22.55 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Ruiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.